Aortic stenosis and statins more evidence of "pleotropy"?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 3, 2005, Pages 476-477

  Borer, Jeffrey S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

AORTA STENOSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEATH; EDITORIAL; HEART VALVE REPLACEMENT; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL;

AORTIC VALVE STENOSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; RISK FACTORS;

EID: 14644390958     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000157932.72212.de     Document Type: Editorial

References (17)

1. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993:21:1220-1225.
2. Borer JS, Jason M, Devereux RB, Fisher J, Green MV, Bacharach SL, Pickering T. Laragh JH. Function of the hypertrophied left ventricle at rest and exercise: hypertension and aortic stenosis. Am J Med 1983; 75:Suppl III:34-39.
3. Osier W, Gibson A. Diseases of the valves of the heart. In: Osler W, McCrae T, eds. Modern Medicine, Its Theory and Practice. Volume 4. Philadelphia, Pa: Lea & Febiger; 1908:205-269.
4. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE. Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997;29: 630-634.
5. Deutscher S, Rockette H, Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chron D. 1984;37: 407-415.
6. Peltier M, Trojette F. Sarano ME, Grigioni F, Slama MA. Tribouilloy CM. Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve. Am J Cardiol. 2003;91:97-99.
7. Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP. Association between apolipoprotein E alleles and calcifc valvular heart disease. Circulation. 2003; 108:1804-1808.
8. Gerber IL, Stewart RA, Hammett CJ, Legget ME, Oxenham H, West TM, French JK, White HD. Effect of aortic valve replacement on C-reactive protein in non-rheumatic aortic stenosis. Am J Cardiol. 2003;92: 1129-1132.
9. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP. Singh RJ, Stone NJ. Bonow RO, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105: 2660-2665.
10. Aronow WS. Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88:693-695.
11. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl co-enzyme A reductase inhibitor treatment and progression of aortic stenosis. J Am Coll Cardiol. 2002;40:1723-1730.
12. Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U, Schemper M, Binder T. Maurer G, Baumgartner H. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110:1291-1295.
13. Otto CM. Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of "degenerative" valvular aortic stenosis: histologic and immunohistochemical studies. Circulation. 1994;90: 844-853.
14. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in non-rheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol. 1999;19:1218-1222.
15. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522-1528.
16. Mohler ER 3rd, Adam LP, McClelland P, Graham L, Hathaway DR. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol. 1997;17:547-552.
17. Wu B. Elmariah S, Kaplan FS, Cheng G, Mohler ER 3rd. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts. implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol. 2005;25:592-597.